Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
Simona Camorani(National Academies of Sciences, Engineering, and Medicine), Antonella Zannetti(Institute of Biostructure and Bioimaging)
Cited by 91
Related Papers
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
|Journal of Experimental & Clinical Cancer Research|2022|97
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
|Scientific Reports|2017|93
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|70
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
|Oncotarget|2015|67
RETRACTED: A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
|International Journal of Molecular Sciences|2020|66